Header Ads

When will the U.S. share its shots?

Here's the latest news from the global pandemic.

When will the U.S. share its vaccines? 

Why isn't the U.S. sharing its extra vaccine doses with the rest of the world? 

America led the world in buying up the messenger RNA vaccines that have proven most effective against Covid-19. It's now starting to lead the world in not using them. 

Across the U.S., there are more than 27 million unused Moderna doses and 35 million from Pfizer and BioNTech,, according to data compiled by the Centers for Disease Control and Prevention. That's led to calls by prominent public health voices to pack America's surplus in dry ice and ship it to places like India, where the outbreak is still raging.

As American vaccinations slow and doses accumulate, the U.S. is at a health, ethical and diplomatic crossroads. Should it continue to buy and distribute millions of mRNA vaccines a week, targeting people who are in no hurry to be vaccinated or who are lower-risk? Or should it pare back its orders and free up drugmakers to send more doses to other countries in need?

While it might seem simple to box up the spares and send them out, the reality is far more complex, according to our latest report on the global vaccine supply.

Pfizer-BioNTech mRNA vaccine

Photographer: Photonews/Photonews

There's no stockpile of tens of millions of Moderna doses in a warehouse, ready to go. Most unused U.S. doses are scattered across tens of thousands of locations: state facilities, local pharmacies, vaccination sites and other locations. 

Pfizer is already sending some shots manufactured in the U.S. overseas. And there may be millions more unused doses from Johnson & Johnson and AstraZeneca available to send out in the coming weeks or months; the exact date is unknown. 

But with the Biden administration rolling back pandemic guidelines on masking, in part to get vaccine fence-sitters to roll up their sleeves, there's little indication the U.S. strategy of ensuring more-than-ample supply at home will change any time soon.

Unfortunately, even if unused U.S. inoculations were sent abroad, they would likely make barely a dent in the need. The globe needs billions of vaccines, not millions, and the places that are in crisis now may burn through their outbreaks before help could arrive.

The Biden administration has said that over the next months it will send out approximately 60 million AstraZeneca doses that haven't been cleared for U.S. use. There are also tens of millions of J&J vaccines that may become available, likely as the American campaign winds down. 

Those are the vaccines the U.S. doesn't need or want. But they are likely what it will give.—Drew Armstrong

Ask us anything

We want to know what you need to know. So ask us. Each week we will select one or two commonly asked questions and put them to our network of experts so you and your families can stay safe—and informed. Get in touch here or via CovidQs@bloomberg.net.

What you should read

Covid Is Airborne. Now Authorities Think So, Too
Scientists seek ventilation overhaul to address airborne germs.
Hybrid Office May Not Be as Flexible as Hoped 
Post-pandemic workplace risks being unsatisfying for employees.
Bankers Flee Wall Street, Head Home to Australia
About 25,000 Australians returned home from overseas last year.
Workers Worried as Some Retailers Ditch Masks 
Retail worker union urges states to maintain mask mandate.
What's Next If Vaccine Incentives Aren't Enough?
Compulsory shots are unpalatable, but may be necessary.

Know someone else who would like this newsletter? Have them sign up here.

Have any questions, concerns, or news tips on Covid-19 news? Get in touch or help us cover the story.

Like this newsletter? Subscribe for unlimited access to trusted, data-based journalism in 120 countries around the world and gain expert analysis from exclusive daily newsletters, The Bloomberg Open and The Bloomberg Close.

No comments